| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/08/2005 | US6852511 Heat-inducible promoter |
| 02/08/2005 | US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence |
| 02/08/2005 | US6852484 Contacting Asparagine Synthase polypeptide with test compound; detecting presence or absence of binding between test compound and Asparagine Synthase polypeptide, wherein binding indicates that test compound is candidate for antibiotic |
| 02/08/2005 | US6852482 For drug screening; Alzheimer's disease prophylaxis/therapy |
| 02/08/2005 | US6852346 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability |
| 02/08/2005 | US6852322 Surface proteins of Leptospira |
| 02/08/2005 | US6852319 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin |
| 02/08/2005 | US6852315 Epoxidation of carbon-carbon double bond with membrane bound peroxygenase |
| 02/08/2005 | CA2323726C Control of gene expression |
| 02/08/2005 | CA2302551C .beta.-fructofuranosidase and its gene |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010794A2 Method for determining metabolic flux affecting substance production |
| 02/03/2005 | WO2005010208A1 Improved method of amplifying atp and use thereof |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010197A2 A systemic small rna signaling system in plants |
| 02/03/2005 | WO2005010191A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | WO2005010176A1 Method for making polypeptide variants by combinatorial fragment exchange |
| 02/03/2005 | WO2005010175A1 Method for producing l-lysine or l-threonine using escherichia bacteria having attnuated malic enzyme activity |
| 02/03/2005 | WO2005010174A2 Methods for use of an lkb1/strad7mo25 complex |
| 02/03/2005 | WO2005010166A2 P450 oxygenases and methods of use |
| 02/03/2005 | WO2005010156A2 Genes encoding carotenoid compounds |
| 02/03/2005 | WO2005009948A2 Peptide inhibitors of beta-lactamases |
| 02/03/2005 | WO2005009115A2 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | WO2004097012A3 Phospholipase and method of producing it |
| 02/03/2005 | WO2004083250A9 Construct comprising recognition domain of antibody against von willebrand factor-specific cleaving enzyme |
| 02/03/2005 | WO2004065551A3 Polynucleotide encoding a novel acyl coenzyme a, monoacylglycerol acyltransferase-3 (mgat3), and uses thereof |
| 02/03/2005 | WO2004042045A3 Crystal structures of bacterial thymidylate kinases |
| 02/03/2005 | WO2004035749A3 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS Kip3 KINESIN PROTEIN |
| 02/03/2005 | WO2004002416A3 Methods and materials for treating human papillomavirus infections |
| 02/03/2005 | WO2003083084A3 Protein modification and maintenance molecules |
| 02/03/2005 | WO2003083082A3 Enzymes |
| 02/03/2005 | WO2003064620A3 Hepsin substrates and prodrugs |
| 02/03/2005 | WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling |
| 02/03/2005 | US20050028233 Plant fatty acid amide hydrolases |
| 02/03/2005 | US20050028232 Recombination polypeptide for use as gene transfer tool in plant genetic engineering; tissue engineering |
| 02/03/2005 | US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 02/03/2005 | US20050027113 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 02/03/2005 | US20050027109 Preparing genetically engineered therapeutic protein fusion comprised of antibody constant region for use in treatment of metabolic disorders |
| 02/03/2005 | US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders |
| 02/03/2005 | US20050027107 Bioassay to determine inhibition of the peptidyl-prolyl isomerase activity of a Pin1 protein; antimitotic, antiproliferative agents |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026804 Proteolytic enzyme for use in detergents, laundering; transformed nucleic acid |
| 02/03/2005 | US20050026293 Autonomously replicating biomolecule for use as gene transfer tool in genetic engineering |
| 02/03/2005 | US20050026280 Arabidopsis thaliana mutant for use as plant model for monitoring light absorption and photosynthesis in plants |
| 02/03/2005 | US20050026270 Using reverse phase high performance liquid chromatography to isolate stable lantibiotic |
| 02/03/2005 | US20050026269 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/03/2005 | US20050026268 Phytase from Bacillus subtilis, gene encoding said phytase, method for its production and use |
| 02/03/2005 | US20050026267 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/03/2005 | US20050026266 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
| 02/03/2005 | US20050026265 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders |
| 02/03/2005 | US20050026258 Mutant N-acetylglutamate synthase and method for L-arginine production |
| 02/03/2005 | US20050026256 Aspartyl protease for use as tool in identifying modulators for use in treatment and prevention of nervous system disorders |
| 02/03/2005 | US20050026252 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 02/03/2005 | US20050026250 Phosphite dehydrogenase mutants for nicotinamide cofactor regeneration |
| 02/03/2005 | US20050026249 Preparing trangenic cells for use as bioreactors for production of glucocerebrosidase for use in treatment of gaucher's disease |
| 02/03/2005 | US20050026246 Method for generating diversity |
| 02/03/2005 | US20050026244 Recombinant narbonolide polyketide synthase |
| 02/03/2005 | US20050026236 PDE 10 cell-based assay and sequences |
| 02/03/2005 | US20050026234 Chimeric phosphorylation indicator comprising fluorescent protein and phosphoaminoacid binding domain for use as diagnostic indicator of kinase activity in different compartments of organelles |
| 02/03/2005 | US20050026233 Using bioassay for loss-of-function mutations in protein kinase (LKB1) as diagnostic tool in detection of cell proliferative disorders; AMP-activated protein kinase (AMPK) and treatment of diabetic, cardiovascular and dietetic disorders |
| 02/03/2005 | US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/03/2005 | US20050026226 Serum Paraoxonase |
| 02/03/2005 | US20050026214 Method of identifying glycosyl transferase binding compounds |
| 02/03/2005 | US20050026210 Expression vector comprising antisense nucleotide sequence associated with suppression of polynucleotides coding enzymatic polypeptide associated with the conversion of 1-propenylsulfenic acid to thiopropanal S-oxide; transgenic plants and food processing |
| 02/03/2005 | US20050026184 Using serine/threoine kinases (ALK-7) as screening tools in identifying modulators for treatment of nervous system disorders |
| 02/03/2005 | US20050026162 Compositions and methods for the modification of gene expression |
| 02/03/2005 | US20050026157 Enzymatic fusion protein comprising cleavage and nuclear localization domain for use gene targeting tool in gene therapeutics |
| 02/03/2005 | US20050026149 Expression vector comprising chimeric nucleotide comprising nuclear, choloroplast and/or mitochondrial localization signals for use as tools in transfer of heterologous genes into preferential genomes |
| 02/03/2005 | US20050026147 Enzyme blend comprising DNA polymerase and repair enzymes for correcting apurinic/apyrimidinic (AP) damages in polynucleotide sequence |
| 02/03/2005 | US20050025838 Conditioned compositions for tissue restoration |
| 02/03/2005 | US20050025722 Removing dental plaque with krill enzymes |
| 02/03/2005 | US20050022952 Method for producing cellulose derivatives |
| 02/03/2005 | DE10332623A1 Zellen und Verfahren zur fermentativen Herstellung von R-alpha-Liponsäure Cells and methods for the fermentative preparation of R-alpha-lipoic acid |
| 02/03/2005 | DE10332151A1 Verfahren zur Herstellung von Carbonsäure-Metallseifen A process for the preparation of carboxylic acid-metal soaps |
| 02/03/2005 | DE10326231A1 Preparing enzyme granules, useful in nutritional, cleaning and pharmaceutical compositions, by spraying enzyme solution into gas stream containing solid particles, followed by drying and granulation |
| 02/03/2005 | CA2532939A1 Plant cell cycle genes and methods of use |
| 02/03/2005 | CA2530085A1 Compositions and methods for the production of betaine lipids |
| 02/03/2005 | CA2527557A1 Genes encoding carotenoid compounds |
| 02/02/2005 | EP1502952A2 Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus |
| 02/02/2005 | EP1502948A1 Ammonia-oxidizing bacteria |
| 02/02/2005 | EP1502603A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM Fc gamma RIIIa POLYMORPHISM |
| 02/02/2005 | EP1502116A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins |
| 02/02/2005 | EP1501950A2 Methods and compositions for dna manipulation |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1501932A2 Method for producing multiple unsaturated fatty acids in plants |
| 02/02/2005 | EP1501925A2 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 02/02/2005 | EP1501923A2 Pak5-related compositions and methods |
| 02/02/2005 | EP1501922A2 METHODS OF MODULATING HEME OXYGENASE−1 EXPRESSION AND TREATING HEME OXYGENASE−1 MEDIATED CONDITIONS |
| 02/02/2005 | EP1501861A1 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501540A1 T-cell epitodes in carboxypeptidase g2 |
| 02/02/2005 | EP1501533A2 Peptide inhibitors of protein kinase c ϝ for pain management |
| 02/02/2005 | EP1501532A2 Peptide inhibitors of protein kinase c |
| 02/02/2005 | EP1501529A1 Mammalian genes modulated during fasting and feeding |
| 02/02/2005 | EP1501465A2 Vectors having both isoforms of beta-hexosaminidase |
| 02/02/2005 | EP1440161A4 7118, a human arginine n-methyltransferase family member and uses therefor |
| 02/02/2005 | EP1436382A4 9136, a human aldehyde dehydrogenase family member and uses therefor |
| 02/02/2005 | EP1412491A4 Compositions and methods utilizing dna polymerases |
| 02/02/2005 | EP1409514A4 Chimeric histone acetyltransferase polypeptides |